Representative Transactions - A Measure of Our Success


Since 1998, Reedland Capital Partners has successfully arranged over $2 billion in financings for companies located all over the United States and Canada in over a dozen different industries, including: technology, healthcare, IT solutions, manufacturing, distribution, retail, gaming, lodging and entertainment.

Following is a sampling of transactions that Reedland Capital Partners has arranged for clients by industry:
A complete list of transactions is available from this password-protected link. To obtain a password, contact the site administrator.

DATE INDUSTRY VALUE   TRANSACTION TYPE
November 2011 Pharmaceuticals $50,000,000*   Committed Equity Facility
August 2011 Technology $50,000,000*   Committed Equity Facility
May 2011 REIT $40,000,000*   Committed Equity Facility
November 2010 Technology $35,000,000    Revolving Credit Facility
October 2010 Biopharmaceuticals $35,000,000*   Committed Equity Facility
August 2010 Technology $60,000,000*   Committed Equity Facility
August 2010 REIT $100,000,000*   Committed Equity Facility
July 2010 Pharmaceuticals $50,000,000*   Committed Equity Facility
July 2010 Biopharmaceuticals $40,000,000*   Committed Equity Facility
July 2010 Biotechnology $20,000,000*   Committed Equity Facility
June 2010 Beverages $10,000,000*   Committed Equity Facility
June 2010 Healthcare $15,000,000*   Committed Equity Facility
May 2010 Biopharmaceuticals $25,000,000*   Committed Equity Facility
January 2010 Biopharmaceuticals $25,000,000*   Committed Equity Facility
November 2009 Biopharmaceuticals $60,000,000*   Committed Equity Facility
October 2009 Biotechnology $35,000,000    Equity
October 2009 Technology $25,000,000*   Committed Equity Facility
October 2009 Biotechnology $35,000,000    Equity
September 2009 Biopharmaceuticals $60,000,000*   Managed Equity Facility
August 2009 Biopharmaceuticals $40,000,000*   Committed Equity Facility
August 2009 Biopharmaceuticals $60,000,000*   Committed Equity Facility
October 2008 Biotechnology $50,000,000*   Committed Equity Facility
October 2008 Biopharmaceuticals $60,000,000*   Committed Equity Facility
July 2008 Biotechnology $192,000,000    Co-Advisor to Company Under Acquisition
March 2008 Biopharmaceuticals $50,000,000*   Committed Equity Facility (2008)
July 2007 Biotechnology $54,000,000‡   Sale of Company
October 2007 Biotechnology $130,000,000*   Committed Equity Facility
September 2007 Biotechnology $100,000,000*   Committed Equity Facility
May 2007 Hospitality/Hotels $100,000,000    Senior Mortgage
May 2007 Hospitality/Hotels $27,000,000    Mezzanine Financing
February 2007 Biotechnology $50,000,000*   Committed Equity Facility
December 2006 Pharmaceuticals $30,000,000*   Committed Equity Facility
October 2006 Pharmaceuticals $75,000,000*   Committed Equity Facility
September 2006 Pharmaceuticals $150,000,000*   Committed Equity Facility
September 2006 Biotechnology $75,000,000*   Committed Equity Facility
June 2006 Pharmaceuticals $75,000,000*   Committed Equity Facility
June 2006 Biotechnology $75,000,000*   Committed Equity Facility
June 2006 Healthcare $3,000,000    Equity
April 2006 Biotechnology $200,000,000*   Committed Equity Facility
December 2005 Technology $6,500,000    Venture Debt Facility
August 2005 Healthcare $32,000,000    Equity
July 2005 Pharmaceuticals $77,000,000    Equity
July 2005 Pharmaceuticals $56,000,000    Senior Debt Facility
April 2004 Tobacco $13,000,000    Equity
February 2004 Biotechnology $25,000,000    Equity
February 2004 Biotechnology $237,000,000    Committed Equity Facility
February 2004 Biotechnology $6,200,000    Equity
October 2003 Mobile Homes/RVs $20,000,000    Equity
September 2003 Pharmaceuticals $115,000,000    Equity (Series D)
June 2000 Technology $191,000,000    Equity
*Amount reflects overall purchase commitment(s) facilitated by Reedland and not necessarily the total amount of securities that will be sold pursuant to applicable purchase agreements.

** Facilitated via third party.

Amount inclusive of up to an additional $12MM in 2009 contingent payments and product royalties.
HomeOur CompanyOur TeamServicesTransactions
ResourcesNews CenterContact Us

Copyright © 2011 Reedland Capital Partners. All rights reserved. Read disclaimer.
Securities and investment advisory services offered through Financial West Group
Member
FINRA/SIPC